Greenwich Pharmaceuticals Inc. regulatory update

GRPI filed a product license application in France and the Netherlands for the use of Therafectin (amiprilose HCI) in rheumatoid arthritis.GRPI filed in the U.K. and Ireland earlier this summer and in...